Gold nanoparticle conjugate‐based lateral flow immunoassay (LFIA) for rapid detection of RBD antigen of SARS‐CoV‐2 in clinical samples using a smartphone‐based application

The coronavirus disease 2019 (COVID‐19) pandemic has emphasized the need for development of a rapid diagnostic device for the effective treatment and its mitigation. Lateral flow immunoassay (LFIA) belongs to a class of diagnostic devices, which has the benefit of providing quick results, easy to ha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2023-01, Vol.95 (1), p.e28416-n/a
Hauptverfasser:	Prakashan, Drishya, Shrikrishna, Narlawar S., Byakodi, Manisha, Nagamani, K., Gandhi, Sonu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antigens Conjugates Coronaviruses COVID-19 COVID-19 - diagnosis Gold gold nanoparticles Humans Immunoassay Immunoassay - methods lateral flow immunoassay Metal Nanoparticles - chemistry Nanoparticles Pandemics Pore size Portable equipment RBD antigen Room temperature SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Shelf life Silver Smartphone Smartphones Storage stability Viral diseases Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!